Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)

NCT04140305 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
188
Enrollment
INDUSTRY
Sponsor class

Stopped Business objective has changed

Conditions

Interventions

Sponsor

Celgene